Morgan Stanley’s Celldex Therapeutics CLDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.5M | Sell |
661,518
-241,364
| -27% | -$4.91M | ﹤0.01% | 3164 |
|
2025
Q1 | $16.4M | Sell |
902,882
-441,217
| -33% | -$8.01M | ﹤0.01% | 2892 |
|
2024
Q4 | $34M | Buy |
1,344,099
+908,281
| +208% | +$23M | ﹤0.01% | 2218 |
|
2024
Q3 | $14.8M | Buy |
435,818
+271,826
| +166% | +$9.24M | ﹤0.01% | 3093 |
|
2024
Q2 | $6.07M | Sell |
163,992
-212,129
| -56% | -$7.85M | ﹤0.01% | 3737 |
|
2024
Q1 | $15.8M | Sell |
376,121
-940,609
| -71% | -$39.5M | ﹤0.01% | 2946 |
|
2023
Q4 | $52.2M | Buy |
1,316,730
+793,030
| +151% | +$31.5M | ﹤0.01% | 2403 |
|
2023
Q3 | $14.4M | Buy |
523,700
+385,916
| +280% | +$10.6M | ﹤0.01% | 2783 |
|
2023
Q2 | $4.68M | Sell |
137,784
-355,261
| -72% | -$12.1M | ﹤0.01% | 3823 |
|
2023
Q1 | $17.7M | Buy |
493,045
+289,356
| +142% | +$10.4M | ﹤0.01% | 2560 |
|
2022
Q4 | $9.08M | Buy |
203,689
+306
| +0.2% | +$13.6K | ﹤0.01% | 3183 |
|
2022
Q3 | $5.72M | Sell |
203,383
-278,644
| -58% | -$7.84M | ﹤0.01% | 3565 |
|
2022
Q2 | $13M | Sell |
482,027
-536,997
| -53% | -$14.5M | ﹤0.01% | 2781 |
|
2022
Q1 | $34.7M | Buy |
1,019,024
+713,091
| +233% | +$24.3M | ﹤0.01% | 1568 |
|
2021
Q4 | $11.8M | Buy |
305,933
+128,397
| +72% | +$4.96M | ﹤0.01% | 2761 |
|
2021
Q3 | $9.58M | Buy |
177,536
+54,377
| +44% | +$2.94M | ﹤0.01% | 2939 |
|
2021
Q2 | $4.12M | Buy |
123,159
+101,154
| +460% | +$3.38M | ﹤0.01% | 3983 |
|
2021
Q1 | $453K | Buy |
22,005
+2,459
| +13% | +$50.6K | ﹤0.01% | 5206 |
|
2020
Q4 | $343K | Buy |
19,546
+3,667
| +23% | +$64.4K | ﹤0.01% | 5290 |
|
2020
Q3 | $236K | Sell |
15,879
-7,263
| -31% | -$108K | ﹤0.01% | 5023 |
|
2020
Q2 | $301K | Buy |
23,142
+3,639
| +19% | +$47.3K | ﹤0.01% | 4878 |
|
2020
Q1 | $33K | Sell |
19,503
-1,667
| -8% | -$2.82K | ﹤0.01% | 5616 |
|
2019
Q4 | $48K | Buy |
21,170
+11,724
| +124% | +$26.6K | ﹤0.01% | 5869 |
|
2019
Q3 | $20K | Sell |
9,446
-1,686
| -15% | -$3.57K | ﹤0.01% | 6014 |
|
2019
Q2 | $30K | Buy |
11,132
+8,774
| +372% | +$23.6K | ﹤0.01% | 5802 |
|
2019
Q1 | $11K | Sell |
2,358
-3,411
| -59% | -$15.9K | ﹤0.01% | 6152 |
|
2018
Q4 | $17K | Buy |
5,769
+2,956
| +105% | +$8.71K | ﹤0.01% | 6045 |
|
2018
Q3 | $20K | Sell |
2,813
-31,157
| -92% | -$222K | ﹤0.01% | 6131 |
|
2018
Q2 | $256K | Sell |
33,970
-2,440
| -7% | -$18.4K | ﹤0.01% | 5449 |
|
2018
Q1 | $1.27M | Buy |
36,410
+7,505
| +26% | +$262K | ﹤0.01% | 4377 |
|
2017
Q4 | $1.23M | Sell |
28,905
-7,038
| -20% | -$300K | ﹤0.01% | 4405 |
|
2017
Q3 | $1.54M | Buy |
35,943
+3,483
| +11% | +$149K | ﹤0.01% | 4107 |
|
2017
Q2 | $1.2M | Sell |
32,460
-1,434
| -4% | -$53.1K | ﹤0.01% | 4238 |
|
2017
Q1 | $1.84M | Sell |
33,894
-12,099
| -26% | -$655K | ﹤0.01% | 3883 |
|
2016
Q4 | $2.44M | Sell |
45,993
-1,845
| -4% | -$98K | ﹤0.01% | 3756 |
|
2016
Q3 | $2.9M | Buy |
47,838
+8,910
| +23% | +$540K | ﹤0.01% | 3183 |
|
2016
Q2 | $2.56M | Buy |
38,928
+1,522
| +4% | +$100K | ﹤0.01% | 3215 |
|
2016
Q1 | $2.12M | Sell |
37,406
-16,218
| -30% | -$920K | ﹤0.01% | 3302 |
|
2015
Q4 | $12.6M | Buy |
53,624
+121
| +0.2% | +$28.5K | ﹤0.01% | 1778 |
|
2015
Q3 | $8.46M | Sell |
53,503
-4,123
| -7% | -$652K | ﹤0.01% | 2133 |
|
2015
Q2 | $21.8M | Buy |
57,626
+675
| +1% | +$255K | 0.01% | 1421 |
|
2015
Q1 | $23.8M | Sell |
56,951
-3,700
| -6% | -$1.55M | 0.01% | 1319 |
|
2014
Q4 | $16.6M | Buy |
60,651
+8,896
| +17% | +$2.44M | 0.01% | 1613 |
|
2014
Q3 | $10.1M | Sell |
51,755
-4,865
| -9% | -$946K | ﹤0.01% | 2007 |
|
2014
Q2 | $13.9M | Buy |
56,620
+6,836
| +14% | +$1.67M | 0.01% | 1739 |
|
2014
Q1 | $13.2M | Buy |
49,784
+7,080
| +17% | +$1.88M | 0.01% | 1732 |
|
2013
Q4 | $15.5M | Buy |
42,704
+5,347
| +14% | +$1.94M | 0.01% | 1564 |
|
2013
Q3 | $19.9M | Buy |
37,357
+1,652
| +5% | +$878K | 0.01% | 1235 |
|
2013
Q2 | $8.36M | Buy |
+35,705
| New | +$8.36M | ﹤0.01% | 1840 |
|